- Nachrichtendetail
-
03.07.2024 14:04:13 - dpa-AFX: *J&J : HEALTH CANADA AUTHORIZES RYBREVANT COMBINATION FOR EGFR EXON 20 NON-SMALL CELL LUNG CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Johnson & Johnson | 853260 | NYSE | 161,200 | 21.08.24 21:51:03 | +1,040 | +0,65% | 161,200 | 161,210 | 160,000 | 160,160 |
